Large Sad Dog Golden Retreiver - 2CPD Seminars/Webinars

Case Studies / Testimonials

The dramatic drop in the cLBT in response to therapy, confirmed ultrasonographically as a complete remission (CR), would validate the usefulness of the test in this case to indicate a treatment response. The results of the follow up monitoring tests are in the mid-range for patients free of disease and in ongoing remission.
Iain Grant BVSC MRCVS Dip ACVIM (medical oncology), University of Glasgow
Since the launch of the new cLBT test we have used it with good results. The first case we chose was a 15yr old Labrador who had chronic weight loss. He has no external signs of lymphoma, but due to his age and intermittent GI signs, alimentary lymphoma was a differential. Unfortunately the test came back strongly suggestive of lymphoma. His owners are reluctant to treat with full blown chemotherapy, but are very happy to have a diagnosis for their dogs weight loss. This has given us the confidence to consider the cLBT as part of our diagnostic procedure where we suspect, or wish to rule out lymphoma. As it is very difficult to diagnose lymphoma until it is quite apparent, it is good to know we now have a simple blood test that can help in ruling this condition in or out of our list of differentials. We have since used the test again to confirm a dog is unlikely to have lymphoma, as his owner was very concerned about the disease, after losing her last dog to the same condition. It has put her mind at rest no end.
Bridgenorth Veterinary Centre
Any test which helps further predict survival and remission times will be of great benefit to our clients. Also, being able to more accurately assess remission status and early relapse may help us devise patient specific chemotherapy regimes in the future.
Simon Tappin, MA VetMB CertSAM DipECVIM-CA MRCVS – Dick White Referrals, UK
After a dog completes chemotherapy, routine monitoring is recommended. But if a dog has a long remission, the owner can get tired of coming back every month for recheck exams and monitoring for relapse. Unfortunately clients often book a recheck visit when the relapse is advanced and the dog is feeling unwell. The cLBT is a useful test to keep a closer eye on these cases; we can then proactively schedule a recheck appointment sooner if the test is positive. I have had cases where the cLBT precedes the enlarged lymph nodes and the clinical relapse, allowing me to recommend a recheck sooner and confirming relapse earlier than I could without the test
Sue Ettinger, DVM, Diplomate ACVIM (Oncology) – New York, USA
Do you have any cases where the cLBT has been beneficial for identifying lymphoma or tracking the remission status of the animal? Please contact our marketing team with your experience of cLBT and as a thank you we’ll send some foodie treats to your practice (UK only).
Click to view past and upcoming events relating to canine lymphoma

Recent Publications / Clinical Papers

Press Releases